NCT01032057 Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01031056 Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers Status WITHDRAWN Phase N/A
NCT01025882 Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT01025570 A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT01020006 Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine Status COMPLETED Phase PHASE2
NCT01017822 Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT01015820 Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer Status COMPLETED Phase NA
NCT01012362 Study of Pazopanib and Ixabepilone in Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT00994110 Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess Status COMPLETED Phase PHASE3
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer Status COMPLETED Phase PHASE1
NCT00983268 Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00974610 Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. Status COMPLETED Phase N/A
NCT00968175 Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer Status COMPLETED Phase NA
NCT00967603 Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00967577 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00967291 Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00966706 Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer Status COMPLETED Phase PHASE2